These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9710118)

  • 1. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions.
    Romanic AM; Arleth AJ; Willette RN; Ohlstein EH
    Circ Res; 1998 Aug; 83(3):264-9. PubMed ID: 9710118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking.
    Shainoff JR; Urbanic DA; DiBello PM
    J Biol Chem; 1991 Apr; 266(10):6429-37. PubMed ID: 1672529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.
    Samokhin GP; Lorand L
    J Biol Chem; 1995 Sep; 270(37):21827-32. PubMed ID: 7665605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis.
    Siebenlist KR; Mosesson MW
    J Biol Chem; 1994 Nov; 269(45):28414-9. PubMed ID: 7961782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
    Harpel PC; Gordon BR; Parker TS
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3847-51. PubMed ID: 2524834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase.
    Borth W; Chang V; Bishop P; Harpel PC
    J Biol Chem; 1991 Sep; 266(27):18149-53. PubMed ID: 1680857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi?
    Smith EB; Crosbie L
    Atherosclerosis; 1991 Aug; 89(2-3):127-36. PubMed ID: 1838924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin.
    Matsuka YV; Anderson ET; Milner-Fish T; Ooi P; Baker S
    Biochemistry; 2003 Dec; 42(49):14643-52. PubMed ID: 14661977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
    Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
    J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin is a substrate for blood coagulation factor XIIIa.
    Bale MD; Mosher DF
    Biochemistry; 1986 Sep; 25(19):5667-73. PubMed ID: 2877688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard.
    Puszkin EG; Raghuraman V
    J Biol Chem; 1985 Dec; 260(29):16012-20. PubMed ID: 2866189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen/fibrin in atherogenesis.
    Smith EB; Thompson WD; Crosbie L; Stirk CM
    Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots.
    Wilson CL; Schwarzbauer JE
    J Cell Biol; 1992 Nov; 119(4):923-33. PubMed ID: 1358897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoke contains anticoagulants against fibrin aggregation and factor XIIIa in plasma.
    Galanakis DK; Laurent P; Janoff A
    Science; 1982 Aug; 217(4560):642-5. PubMed ID: 6124042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of covalent binding of lipoprotein(a) [Lp(a)] to fibrin and endothelial cells.
    Liu JN; Kung W; Harpel PC; Gurewich V
    Biochemistry; 1998 Mar; 37(11):3949-54. PubMed ID: 9521716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clotting of mammalian fibrinogens by papain: a re-examination.
    Doolittle RF
    Biochemistry; 2014 Oct; 53(42):6687-94. PubMed ID: 25283163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
    Jeleńska MM; Fesüs L; Kopeć M
    Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.
    Harpel PC; Chang VT; Borth W
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10193-7. PubMed ID: 1438209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a)).
    Smith EB; Cochran S
    Atherosclerosis; 1990 Oct; 84(2-3):173-81. PubMed ID: 2149268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.